Ayush Healthcare's synthetic organic chemical manufacture, especially API intermediates, at Plot No. 6211 in the GIDC Industrial Estate in Ankleshwar, Gujarat, represents various important developments. With a project cost of Rs. 9.7931 crores, creating these essential chemical compounds for Active Pharmaceutical Ingredients (APIs) meets the growing need for inexpensive and accessible medications domestically and globally.
The project's 40 MT/month manufacturing capability allows Ayush Healthcare to meet different API intermediate market demands by handling 10 products at once. Their allocation of 40% of the 5000 sq m area to a green belt highlights their commitment to sustainable industrial methods, which may reduce chemical manufacturing's environmental effect.
Beyond production, the project's infrastructure and utilities, including GIDC infrastructure and DGVCL energy with a diesel generator, demonstrate its stability and resilience. This effort boosts India's pharmaceutical sector and might boost Ankleshwar's economy by luring more enterprises to the industrial region and generating jobs.
Green areas demonstrate Ayush Healthcare's commitment to reducing chemical manufacturing's environmental impact, a step forward in ethical industrial practises.
As on December 2023, The project is now in the stage of receiving approvals. The project has received all necessary clearances.
News by Rahul Yelligetti